April 3, 2018 / 11:39 AM / 8 months ago

BRIEF-Galmed Pharmaceuticals Announces Pricing Of $6 Mln Registered Direct Offering

April 3 (Reuters) - Galmed Pharmaceuticals Ltd:

* ANNOUNCES PRICING OF $6.0 MILLION REGISTERED DIRECT OFFERING

* ENTERED INTO SECURITIES PURCHASE AGREEMENT WITH BIOTECHNOLOGY VALUE FUND, L.P. AND CERTAIN OF ITS AFFILIATES

* DEAL TO BUY, SELL 1 MILLION SHARES, WARRANTS TO PURCHASE 1 MILLION SHARES, FOR $6.00/SHARE, RELATED WARRANT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below